Before the device’s arrival in operating rooms, a patient’s oxygen level was determined through arterial blood gas. The process typically took between 20-30 minutes to draw blood, measure levels, and obtain a result — the delay heightened the risk of severe brain damage, which can occur within minutes of a patient having low oxygen. According to some reports, as many as 10,000 patients die per year because of undetected hypoxemia.
This ability to radically advance medical care through seemingly simple innovations and process flow improvements continues today. In particular, medical robotics innovators have the potential to deliver even more dramatic gains in speed, accuracy, and patient turnaround.
The first generation of medical robotic innovators has already proven the technology’s ability to improve patient outcomes with faster recovery, shorter hospital stays, and fewer complications. One 2022 JAMA study showed that robotics surgery reduced the chance of patient readmission by 52% and reduced complications such as blood clots by 77% compared to patients who had open surgery.
Now, as second-generation robotics companies fill in the gaps left by their predecessors, there is an opportunity to improve on these numbers. While clinical outcomes are at the forefront of design decisions, advancing clinical workflow and efficiency has quickly become an area of increased importance in the global healthcare market. By focusing on these six areas below, innovators and providers may begin to realize greater efficiency and value at scale.
In today’s shift towards value-based care, economics and outcomes are inextricably linked. Delivering the best care possible in the most efficient manner for patients, providers, and payers is paramount.
Innovators that make design decisions with this in mind can differentiate themselves from the competition and build market share more quickly. Forward-thinking developers should be using these six areas of emphasis to leapfrog today’s clinical standards of efficiencies, and marketing and sales teams must then highlight them in their negotiations with health systems and providers.
For all these stakeholders, the key is to remain committed and aligned to this vision for workflow efficiency.
Jian Zhang is a serial entrepreneur who co-founded and served as CEO for two other successful startups prior to founding Noah Medical. He was also employee #2 at Auris Health, which was acquired by Johnson & Johnson for $5.7B in 2019. Prior to joining Auris, he worked at Intuitive Surgical. Jian received his MS and PhD from Columbia University.
To learn more about Noah Medical and the Galaxy System, please visit noahmed.com.
Noah Medical is building the future of medical robotics, and the Galaxy System is Noah Medical’s first commercial robotic system. The company’s mission is to deliver adoptable clinical solutions through innovative endoluminal technologies to enhance the quality of life for patients globally. Based in Silicon Valley and backed by well-known institutional investors, our incredibly talented team of engineers,
innovators and industry leaders bring years of experience from the top robotics, medical device and healthcare companies in the world.
Media Contact:
Adam Marsh
Noah Medical
408-464-3732
press@noahmed.com